RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
PDS Biotechnology Stock

PDS Biotechnology Employees 2025

PDS Biotechnology Employees

15

Ticker

PDSB

ISIN

US70465T1079

WKN

A2PF3F

In 2025, PDS Biotechnology employed 15 people, a 0% change from the 15 number of employees in the previous year.

PDS Biotechnology Aktienanalyse

What does PDS Biotechnology do?

PDS Biotechnology Corporation is a biopharmaceutical company founded in 2005. It is based in New Jersey, USA and employs around 35 employees. The company specializes in the development of drugs and therapies for the treatment of cancer and infectious diseases. PDS Biotechnology's business model is based on the use of a technology platform called Versamune®. This platform allows for the embedding of immunomodulatory agents in vaccines and cancer therapies. The goal is to activate and strengthen the body's immune defense against cancer and infections. PDS has four different divisions: cancer immunotherapies, infectious diseases, vetmedica, and research services. PDS's cancer immunotherapies focus on stimulating the immune system to help the body recognize and fight cancer cells. The Versamune® technology is used in combination with peptide-based vaccines. Versamune® is intended to help generate a strong and sustained immune response. The most advanced projects in cancer immunotherapy include PD1 vaccines and the PD1 vaccine combination program. PDS is also working on the development of Versamune®-based treatment options in the areas of infectious diseases and vetmedica. Advanced platform technologies have been developed based on the use of Versamune® and choice peptide fusion proteins. In the field of research services, PDS offers a range of services related to its technology platform. These include the manufacturing of Versamune® products, preclinical studies, as well as analysis and consulting. One of PDS's projects, currently being tested in clinical phase IIa, is a vaccine against human papillomavirus (HPV). HPV is a virus that plays a significant role in the development of various types of cancer, such as cervical cancer. The vaccine aims to strengthen the immune system against HPV and thereby reduce the risk of developing cancer. In addition to developing new drugs, PDS has also focused on improving existing treatment options. The company collaborates closely with research institutions and other companies to leverage new insights and technologies in order to develop better therapies. PDS Biotechnology is an emerging company with promising products and a strong commitment to developing groundbreaking therapies for the treatment of cancer and infectious diseases. Through the use of its Versamune® technology and expertise in immunotherapy, the company has the potential to change the future of medicine and improve the lives of millions of people. PDS Biotechnology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining PDS Biotechnology's Employee Base

PDS Biotechnology's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding PDS Biotechnology's operational capacity and future potential.

Year-to-Year Comparison

Assessing PDS Biotechnology's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

PDS Biotechnology's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in PDS Biotechnology’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about PDS Biotechnology stock

How many employees does PDS Biotechnology have this year?

PDS Biotechnology has 15 undefined employees this year.

How many employees did PDS Biotechnology have compared to the previous year?

Compared to the previous year, PDS Biotechnology had 0% more employees.

What impact did the number of employees have on the company PDS Biotechnology?

The number of employees has a direct impact on the efficiency and productivity of PDS Biotechnology. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of PDS Biotechnology?

The number of employees can also have an impact on investors of PDS Biotechnology, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of PDS Biotechnology affect the company?

An increase in equity of PDS Biotechnology can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in PDS Biotechnology's equity affect the company?

A reduction in equity of PDS Biotechnology can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of PDS Biotechnology?

Some factors that can influence the equity of PDS Biotechnology include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of PDS Biotechnology so important for investors?

The equity of PDS Biotechnology is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at PDS Biotechnology influence the company?

The number of employees at PDS Biotechnology can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at PDS Biotechnology evolved in recent years?

In recent years, the number of employees at PDS Biotechnology has changed by 0.

How many employees does PDS Biotechnology currently have?

PDS Biotechnology currently has 15 undefined employees.

Why is the number of employees important for investors of PDS Biotechnology?

The number of employees is important for investors of PDS Biotechnology as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can PDS Biotechnology take to change the number of employees?

To change the number of employees, PDS Biotechnology can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does PDS Biotechnology pay?

Over the past 12 months, PDS Biotechnology paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, PDS Biotechnology is expected to pay a dividend of 0 USD.

What is the dividend yield of PDS Biotechnology?

The current dividend yield of PDS Biotechnology is .

When does PDS Biotechnology pay dividends?

PDS Biotechnology pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of PDS Biotechnology?

PDS Biotechnology paid dividends every year for the past 0 years.

What is the dividend of PDS Biotechnology?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is PDS Biotechnology located?

PDS Biotechnology is assigned to the 'Health' sector.

Wann musste ich die Aktien von PDS Biotechnology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of PDS Biotechnology from 1/7/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/7/2025.

When did PDS Biotechnology pay the last dividend?

The last dividend was paid out on 1/7/2025.

What was the dividend of PDS Biotechnology in the year 2024?

In the year 2024, PDS Biotechnology distributed 0 USD as dividends.

In which currency does PDS Biotechnology pay out the dividend?

The dividends of PDS Biotechnology are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The PDS Biotechnology stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von PDS Biotechnology

Our stock analysis for PDS Biotechnology Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PDS Biotechnology Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.